Pressmeddelanden

Coegin Pharma reports strong clinical results for Follicopeptide® in eyelashes - statistically significant increase in eyelash length confirmed Coegin Pharma AB ("Coegin" or the "Company") today announces encouraging results from a completed 56-day clinical study evaluating Follicopeptide® Lash Gel Serum for eyelashes. V...
REG MAR
Coegin Pharma AB publishes its interim report for the second quarter of 2026 Summary of interim reportThe second quarter of 2026 represents another important step in Coegin Pharma's transformation. Less than a year ago the Company was preparing its first...
Coegin Pharma provides an update on product development and upcoming product launches Coegin Pharma AB ("Coegin" or the "Company") today provides an update on the expansion of its Follicopeptide®-based product portfolio. Development is progressing across several n...
REG
Communiqué from the Extraordinary General Meeting of Coegin Pharma AB (publ) Today, on July 22, 2026, the Extraordinary General Meeting of Coegin Pharma AB (publ) ("Coegin Pharma" or the "Company") was held. A summary of the resolution passed by the Extra...
REG
Notice of extraordinary general meeting in Coegin Pharma AB (publ) The shareholders of Coegin Pharma AB, reg. no. 559078-0465, are hereby invited to attend the Extraordinary General Meeting on Wednesday, 22 July 2026 at 2:00 p.m. at Medicon Vill...
REG
Kallelse till extra bolagsstämma i Coegin Pharma AB (publ) Aktieägarna i Coegin Pharma AB, org. nr 559078-0465 kallas härmed till extra bolagsstämma onsdagen den 22 juli 2026 kl. 14.00 på Medicon Village, Scheeletorget 1, i Lund. Rätt at...
Visa fler pressmeddelanden

Rapporter

Datum Rubrik
Interim report January-June 2026
Interim Report Q1 2026
Annual report 2025

Video

Finansiell kalender

Om Coegin Pharma

Coegin Pharma är ett svenskt innovationsbolag som utvecklar och kommersialiserar avancerade kosmetiska teknologier för hår och hud.

Webbplats
www.coeginpharma.com
Bransch
Bioteknik

Prenumerera

Få löpande information från Coegin Pharma via e-post.

Språk
Nyhetstyper

Handelsinformation

Kurs 2,92 SEK (2026-09-07)
Förändring −46,91% (2025-09-05)
Marknad NGM Growth Market Kortnamn COEGIN ISIN-kod SE0020357754